Axillary Dissection in ۴۴ Breast Cancer Patients without Seroma Formation
محل انتشار: مجله سرطان خاورمیانه، دوره: 2، شماره: 2
سال انتشار: 1390
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 194
فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_MISJ-2-2_004
تاریخ نمایه سازی: 25 آبان 1402
چکیده مقاله:
Background: Seroma formation is a common problem following axillary dissection. It is probably caused by a local inflammatory response. Local steroids may prevent this problem by inhibiting inflammatory response at the wound site. Methods: This randomized prospective study was undertaken to evaluate the effect of local triamcinolone injection on seroma formation following axillary dissection. In addition, other wound complications were recorded. A total of ۴۴ women who underwent axillary dissection were randomized to receive either ۴۰ mg intracavitary triamcinolone (Group T, n=۲۲) or saline (Group C, n=۲۲) on their first postoperative visit. Drains were removed if ۲۴-hour drainage was Results: No wound complications (including seroma formation) were observed in either group in four follow-up visits during the first month after surgery. Conclusion: In our study, in contrast to previous studies, seroma formation was not a common complication following axillary dissection. We could not evaluate the effect of local triamcinolone on seroma formation, although it apparently had no unfavorable effect on this potential complication. According to this study, axillary dissection can be a safe procedure if optimal surgical techniques and meticulous dissections are used, and if drain removal is timed appropriately.
کلیدواژه ها:
نویسندگان
Sedigheh Tahmasebi
Department of Surgical Oncology, Shahid Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Armin Amirian
Department of Surgical Oncology, Shahid Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Abdolrasul Talei
Department of Surgical Oncology, Shahid Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran